Principal Biostatistician – Early Phase (PK) ????CAD $240,000 base????Fully remote - Canada
Influence early-phase clinical strategy and PK-driven decision making across an innovative development portfolio ????
About
Join a leading global provider within the biotech/pharma space, supporting an innovative clinical development portfolio focused on advancing therapies that address significant unmet medical needs.
This role sits within early clinical development, with a strong emphasis on healthy volunteer studies and PK/PD endpoints. The environment is scientifically rigorous, collaborative, and fast-paced, with meaningful upcoming development milestones.
Why This Role Matters
Early-phase studies set the trajectory for an entire program. In this role, you will provide senior-level statistical expertise to ensure robust design, high-quality analysis, and clear interpretation of PK data that directly informs downstream clinical and regulatory strategy.
The team is seeking someone with genuine hands-on PK experience who enjoys owning their work while collaborating closely with Clinical Pharmacology, Clinical Development, and Data Management.
What You Will Do
Provide statistical leadership for early-phase clinical studies with PK/PD endpointsAuthor statistical sections of protocols, including sample size calculationsDevelop and review SAPs, randomization specifications, datasets, and TLFsPerform and validate analyses using SAS (R a plus)Contribute to clinical study reports and regulatory documentationPartner cross-functionally to ensure aligned timelines and high-quality deliverablesSupport exploratory and IND-enabling analyses where required
What You Bring
PhD in Statistics/Biostatistics with 3+ years of industry experience, or MS with 5+ years2+ years of hands-on experience analyzing non-compartmental PK endpoints in industryStrong understanding of ICH GCP and regulatory expectations for clinical pharmacology studiesExperience working with CDISC standards (SDTM, ADaM, CDASH)Proficiency in SAS for independent analysis and validationAbility to independently manage projects and make sound statistical decisionsStrong communication skills and experience collaborating with cross-functional teams
Preferred: Exposure to statistical modeling, simulation methods, or PD/biomarker analyses.
Why It’s Special
Fully remote across CanadaHigh-impact early development workStrong balance of autonomy and collaborationOpportunity suited to someone senior yet still technically hands-onStable environment with long-term visibility
Principal Biostatistician – Early Phase (PK) ????CAD $240,000 base????Fully remote - Canada
Influence early-phase clinical strategy and PK-driven decision making across an innovative development portfolio ????
About
Join a leading global provider within the biotech/pharma space, supporting an innovative clinical development portfolio focused on advancing therapies that address significant unmet medical needs.
This role sits within early clinical development, with a strong emphasis on healthy volunteer studies and PK/PD endpoints. The environment is scientifically rigorous, collaborative, and fast-paced, with meaningful upcoming development milestones.
Why This Role Matters
Early-phase studies set the trajectory for an entire program. In this role, you will provide senior-level statistical expertise to ensure robust design, high-quality analysis, and clear interpretation of PK data that directly informs downstream clinical and regulatory strategy.
The team is seeking someone with genuine hands-on PK experience who enjoys owning their work while collaborating closely with Clinical Pharmacology, Clinical Development, and Data Management.
What You Will Do
Provide statistical leadership for early-phase clinical studies with PK/PD endpointsAuthor statistical sections of protocols, including sample size calculationsDevelop and review SAPs, randomization specifications, datasets, and TLFsPerform and validate analyses using SAS (R a plus)Contribute to clinical study reports and regulatory documentationPartner cross-functionally to ensure aligned timelines and high-quality deliverablesSupport exploratory and IND-enabling analyses where required
What You Bring
PhD in Statistics/Biostatistics with 3+ years of industry experience, or MS with 5+ years2+ years of hands-on experience analyzing non-compartmental PK endpoints in industryStrong understanding of ICH GCP and regulatory expectations for clinical pharmacology studiesExperience working with CDISC standards (SDTM, ADaM, CDASH)Proficiency in SAS for independent analysis and validationAbility to independently manage projects and make sound statistical decisionsStrong communication skills and experience collaborating with cross-functional teams
Preferred: Exposure to statistical modeling, simulation methods, or PD/biomarker analyses.
Why It’s Special
Fully remote across CanadaHigh-impact early development workStrong balance of autonomy and collaborationOpportunity suited to someone senior yet still technically hands-onStable environment with long-term visibility
Principal Biostatistician – Early Phase (PK) ????CAD $240,000 base????Fully remote - Canada
Influence early-phase clinical strategy and PK-driven decision making across an innovative development portfolio ????
About
Join a leading global provider within the biotech/pharma space, supporting an innovative clinical development portfolio focused on advancing therapies that address significant unmet medical needs.
This role sits within early clinical development, with a strong emphasis on healthy volunteer studies and PK/PD endpoints. The environment is scientifically rigorous, collaborative, and fast-paced, with meaningful upcoming development milestones.
Why This Role Matters
Early-phase studies set the trajectory for an entire program. In this role, you will provide senior-level statistical expertise to ensure robust design, high-quality analysis, and clear interpretation of PK data that directly informs downstream clinical and regulatory strategy.
The team is seeking someone with genuine hands-on PK experience who enjoys owning their work while collaborating closely with Clinical Pharmacology, Clinical Development, and Data Management.
What You Will Do
Provide statistical leadership for early-phase clinical studies with PK/PD endpointsAuthor statistical sections of protocols, including sample size calculationsDevelop and review SAPs, randomization specifications, datasets, and TLFsPerform and validate analyses using SAS (R a plus)Contribute to clinical study reports and regulatory documentationPartner cross-functionally to ensure aligned timelines and high-quality deliverablesSupport exploratory and IND-enabling analyses where required
What You Bring
PhD in Statistics/Biostatistics with 3+ years of industry experience, or MS with 5+ years2+ years of hands-on experience analyzing non-compartmental PK endpoints in industryStrong understanding of ICH GCP and regulatory expectations for clinical pharmacology studiesExperience working with CDISC standards (SDTM, ADaM, CDASH)Proficiency in SAS for independent analysis and validationAbility to independently manage projects and make sound statistical decisionsStrong communication skills and experience collaborating with cross-functional teams
Preferred: Exposure to statistical modeling, simulation methods, or PD/biomarker analyses.
Why It’s Special
Fully remote across CanadaHigh-impact early development workStrong balance of autonomy and collaborationOpportunity suited to someone senior yet still technically hands-onStable environment with long-term visibility
Principal Biostatistician – Early Phase (PK) ????CAD $240,000 base????Fully remote - Canada
Influence early-phase clinical strategy and PK-driven decision making across an innovative development portfolio ????
About
Join a leading global provider within the biotech/pharma space, supporting an innovative clinical development portfolio focused on advancing therapies that address significant unmet medical needs.
This role sits within early clinical development, with a strong emphasis on healthy volunteer studies and PK/PD endpoints. The environment is scientifically rigorous, collaborative, and fast-paced, with meaningful upcoming development milestones.
Why This Role Matters
Early-phase studies set the trajectory for an entire program. In this role, you will provide senior-level statistical expertise to ensure robust design, high-quality analysis, and clear interpretation of PK data that directly informs downstream clinical and regulatory strategy.
The team is seeking someone with genuine hands-on PK experience who enjoys owning their work while collaborating closely with Clinical Pharmacology, Clinical Development, and Data Management.
What You Will Do
Provide statistical leadership for early-phase clinical studies with PK/PD endpointsAuthor statistical sections of protocols, including sample size calculationsDevelop and review SAPs, randomization specifications, datasets, and TLFsPerform and validate analyses using SAS (R a plus)Contribute to clinical study reports and regulatory documentationPartner cross-functionally to ensure aligned timelines and high-quality deliverablesSupport exploratory and IND-enabling analyses where required
What You Bring
PhD in Statistics/Biostatistics with 3+ years of industry experience, or MS with 5+ years2+ years of hands-on experience analyzing non-compartmental PK endpoints in industryStrong understanding of ICH GCP and regulatory expectations for clinical pharmacology studiesExperience working with CDISC standards (SDTM, ADaM, CDASH)Proficiency in SAS for independent analysis and validationAbility to independently manage projects and make sound statistical decisionsStrong communication skills and experience collaborating with cross-functional teams
Preferred: Exposure to statistical modeling, simulation methods, or PD/biomarker analyses.
Why It’s Special
Fully remote across CanadaHigh-impact early development workStrong balance of autonomy and collaborationOpportunity suited to someone senior yet still technically hands-onStable environment with long-term visibility
Principal Biostatistician – Early Phase (PK) ????CAD $240,000 base????Fully remote - Canada
Influence early-phase clinical strategy and PK-driven decision making across an innovative development portfolio ????
About
Join a leading global provider within the biotech/pharma space, supporting an innovative clinical development portfolio focused on advancing therapies that address significant unmet medical needs.
This role sits within early clinical development, with a strong emphasis on healthy volunteer studies and PK/PD endpoints. The environment is scientifically rigorous, collaborative, and fast-paced, with meaningful upcoming development milestones.
Why This Role Matters
Early-phase studies set the trajectory for an entire program. In this role, you will provide senior-level statistical expertise to ensure robust design, high-quality analysis, and clear interpretation of PK data that directly informs downstream clinical and regulatory strategy.
The team is seeking someone with genuine hands-on PK experience who enjoys owning their work while collaborating closely with Clinical Pharmacology, Clinical Development, and Data Management.
What You Will Do
Provide statistical leadership for early-phase clinical studies with PK/PD endpointsAuthor statistical sections of protocols, including sample size calculationsDevelop and review SAPs, randomization specifications, datasets, and TLFsPerform and validate analyses using SAS (R a plus)Contribute to clinical study reports and regulatory documentationPartner cross-functionally to ensure aligned timelines and high-quality deliverablesSupport exploratory and IND-enabling analyses where required
What You Bring
PhD in Statistics/Biostatistics with 3+ years of industry experience, or MS with 5+ years2+ years of hands-on experience analyzing non-compartmental PK endpoints in industryStrong understanding of ICH GCP and regulatory expectations for clinical pharmacology studiesExperience working with CDISC standards (SDTM, ADaM, CDASH)Proficiency in SAS for independent analysis and validationAbility to independently manage projects and make sound statistical decisionsStrong communication skills and experience collaborating with cross-functional teams
Preferred: Exposure to statistical modeling, simulation methods, or PD/biomarker analyses.
Why It’s Special
Fully remote across CanadaHigh-impact early development workStrong balance of autonomy and collaborationOpportunity suited to someone senior yet still technically hands-onStable environment with long-term visibility
Principal Biostatistician – Early Phase (PK) ????CAD $240,000 base????Fully remote - Canada
Influence early-phase clinical strategy and PK-driven decision making across an innovative development portfolio ????
About
Join a leading global provider within the biotech/pharma space, supporting an innovative clinical development portfolio focused on advancing therapies that address significant unmet medical needs.
This role sits within early clinical development, with a strong emphasis on healthy volunteer studies and PK/PD endpoints. The environment is scientifically rigorous, collaborative, and fast-paced, with meaningful upcoming development milestones.
Why This Role Matters
Early-phase studies set the trajectory for an entire program. In this role, you will provide senior-level statistical expertise to ensure robust design, high-quality analysis, and clear interpretation of PK data that directly informs downstream clinical and regulatory strategy.
The team is seeking someone with genuine hands-on PK experience who enjoys owning their work while collaborating closely with Clinical Pharmacology, Clinical Development, and Data Management.
What You Will Do
Provide statistical leadership for early-phase clinical studies with PK/PD endpointsAuthor statistical sections of protocols, including sample size calculationsDevelop and review SAPs, randomization specifications, datasets, and TLFsPerform and validate analyses using SAS (R a plus)Contribute to clinical study reports and regulatory documentationPartner cross-functionally to ensure aligned timelines and high-quality deliverablesSupport exploratory and IND-enabling analyses where required
What You Bring
PhD in Statistics/Biostatistics with 3+ years of industry experience, or MS with 5+ years2+ years of hands-on experience analyzing non-compartmental PK endpoints in industryStrong understanding of ICH GCP and regulatory expectations for clinical pharmacology studiesExperience working with CDISC standards (SDTM, ADaM, CDASH)Proficiency in SAS for independent analysis and validationAbility to independently manage projects and make sound statistical decisionsStrong communication skills and experience collaborating with cross-functional teams
Preferred: Exposure to statistical modeling, simulation methods, or PD/biomarker analyses.
Why It’s Special
Fully remote across CanadaHigh-impact early development workStrong balance of autonomy and collaborationOpportunity suited to someone senior yet still technically hands-onStable environment with long-term visibility
Principal Biostatistician – Early Phase (PK) ????CAD $240,000 base????Fully remote - Canada
Influence early-phase clinical strategy and PK-driven decision making across an innovative development portfolio ????
About
Join a leading global provider within the biotech/pharma space, supporting an innovative clinical development portfolio focused on advancing therapies that address significant unmet medical needs.
This role sits within early clinical development, with a strong emphasis on healthy volunteer studies and PK/PD endpoints. The environment is scientifically rigorous, collaborative, and fast-paced, with meaningful upcoming development milestones.
Why This Role Matters
Early-phase studies set the trajectory for an entire program. In this role, you will provide senior-level statistical expertise to ensure robust design, high-quality analysis, and clear interpretation of PK data that directly informs downstream clinical and regulatory strategy.
The team is seeking someone with genuine hands-on PK experience who enjoys owning their work while collaborating closely with Clinical Pharmacology, Clinical Development, and Data Management.
What You Will Do
Provide statistical leadership for early-phase clinical studies with PK/PD endpointsAuthor statistical sections of protocols, including sample size calculationsDevelop and review SAPs, randomization specifications, datasets, and TLFsPerform and validate analyses using SAS (R a plus)Contribute to clinical study reports and regulatory documentationPartner cross-functionally to ensure aligned timelines and high-quality deliverablesSupport exploratory and IND-enabling analyses where required
What You Bring
PhD in Statistics/Biostatistics with 3+ years of industry experience, or MS with 5+ years2+ years of hands-on experience analyzing non-compartmental PK endpoints in industryStrong understanding of ICH GCP and regulatory expectations for clinical pharmacology studiesExperience working with CDISC standards (SDTM, ADaM, CDASH)Proficiency in SAS for independent analysis and validationAbility to independently manage projects and make sound statistical decisionsStrong communication skills and experience collaborating with cross-functional teams
Preferred: Exposure to statistical modeling, simulation methods, or PD/biomarker analyses.
Why It’s Special
Fully remote across CanadaHigh-impact early development workStrong balance of autonomy and collaborationOpportunity suited to someone senior yet still technically hands-onStable environment with long-term visibility
Principal Biostatistician – Early Phase (PK) ????CAD $240,000 base????Fully remote - Canada
Influence early-phase clinical strategy and PK-driven decision making across an innovative development portfolio ????
About
Join a leading global provider within the biotech/pharma space, supporting an innovative clinical development portfolio focused on advancing therapies that address significant unmet medical needs.
This role sits within early clinical development, with a strong emphasis on healthy volunteer studies and PK/PD endpoints. The environment is scientifically rigorous, collaborative, and fast-paced, with meaningful upcoming development milestones.
Why This Role Matters
Early-phase studies set the trajectory for an entire program. In this role, you will provide senior-level statistical expertise to ensure robust design, high-quality analysis, and clear interpretation of PK data that directly informs downstream clinical and regulatory strategy.
The team is seeking someone with genuine hands-on PK experience who enjoys owning their work while collaborating closely with Clinical Pharmacology, Clinical Development, and Data Management.
What You Will Do
Provide statistical leadership for early-phase clinical studies with PK/PD endpointsAuthor statistical sections of protocols, including sample size calculationsDevelop and review SAPs, randomization specifications, datasets, and TLFsPerform and validate analyses using SAS (R a plus)Contribute to clinical study reports and regulatory documentationPartner cross-functionally to ensure aligned timelines and high-quality deliverablesSupport exploratory and IND-enabling analyses where required
What You Bring
PhD in Statistics/Biostatistics with 3+ years of industry experience, or MS with 5+ years2+ years of hands-on experience analyzing non-compartmental PK endpoints in industryStrong understanding of ICH GCP and regulatory expectations for clinical pharmacology studiesExperience working with CDISC standards (SDTM, ADaM, CDASH)Proficiency in SAS for independent analysis and validationAbility to independently manage projects and make sound statistical decisionsStrong communication skills and experience collaborating with cross-functional teams
Preferred: Exposure to statistical modeling, simulation methods, or PD/biomarker analyses.
Why It’s Special
Fully remote across CanadaHigh-impact early development workStrong balance of autonomy and collaborationOpportunity suited to someone senior yet still technically hands-onStable environment with long-term visibility
Principal Biostatistician – Early Phase (PK) ????CAD $240,000 base????Fully remote - Canada
Influence early-phase clinical strategy and PK-driven decision making across an innovative development portfolio ????
About
Join a leading global provider within the biotech/pharma space, supporting an innovative clinical development portfolio focused on advancing therapies that address significant unmet medical needs.
This role sits within early clinical development, with a strong emphasis on healthy volunteer studies and PK/PD endpoints. The environment is scientifically rigorous, collaborative, and fast-paced, with meaningful upcoming development milestones.
Why This Role Matters
Early-phase studies set the trajectory for an entire program. In this role, you will provide senior-level statistical expertise to ensure robust design, high-quality analysis, and clear interpretation of PK data that directly informs downstream clinical and regulatory strategy.
The team is seeking someone with genuine hands-on PK experience who enjoys owning their work while collaborating closely with Clinical Pharmacology, Clinical Development, and Data Management.
What You Will Do
Provide statistical leadership for early-phase clinical studies with PK/PD endpointsAuthor statistical sections of protocols, including sample size calculationsDevelop and review SAPs, randomization specifications, datasets, and TLFsPerform and validate analyses using SAS (R a plus)Contribute to clinical study reports and regulatory documentationPartner cross-functionally to ensure aligned timelines and high-quality deliverablesSupport exploratory and IND-enabling analyses where required
What You Bring
PhD in Statistics/Biostatistics with 3+ years of industry experience, or MS with 5+ years2+ years of hands-on experience analyzing non-compartmental PK endpoints in industryStrong understanding of ICH GCP and regulatory expectations for clinical pharmacology studiesExperience working with CDISC standards (SDTM, ADaM, CDASH)Proficiency in SAS for independent analysis and validationAbility to independently manage projects and make sound statistical decisionsStrong communication skills and experience collaborating with cross-functional teams
Preferred: Exposure to statistical modeling, simulation methods, or PD/biomarker analyses.
Why It’s Special
Fully remote across CanadaHigh-impact early development workStrong balance of autonomy and collaborationOpportunity suited to someone senior yet still technically hands-onStable environment with long-term visibility
Principal Biostatistician – Early Phase (PK) ????CAD $240,000 base????Fully remote - Canada
Influence early-phase clinical strategy and PK-driven decision making across an innovative development portfolio ????
About
Join a leading global provider within the biotech/pharma space, supporting an innovative clinical development portfolio focused on advancing therapies that address significant unmet medical needs.
This role sits within early clinical development, with a strong emphasis on healthy volunteer studies and PK/PD endpoints. The environment is scientifically rigorous, collaborative, and fast-paced, with meaningful upcoming development milestones.
Why This Role Matters
Early-phase studies set the trajectory for an entire program. In this role, you will provide senior-level statistical expertise to ensure robust design, high-quality analysis, and clear interpretation of PK data that directly informs downstream clinical and regulatory strategy.
The team is seeking someone with genuine hands-on PK experience who enjoys owning their work while collaborating closely with Clinical Pharmacology, Clinical Development, and Data Management.
What You Will Do
Provide statistical leadership for early-phase clinical studies with PK/PD endpointsAuthor statistical sections of protocols, including sample size calculationsDevelop and review SAPs, randomization specifications, datasets, and TLFsPerform and validate analyses using SAS (R a plus)Contribute to clinical study reports and regulatory documentationPartner cross-functionally to ensure aligned timelines and high-quality deliverablesSupport exploratory and IND-enabling analyses where required
What You Bring
PhD in Statistics/Biostatistics with 3+ years of industry experience, or MS with 5+ years2+ years of hands-on experience analyzing non-compartmental PK endpoints in industryStrong understanding of ICH GCP and regulatory expectations for clinical pharmacology studiesExperience working with CDISC standards (SDTM, ADaM, CDASH)Proficiency in SAS for independent analysis and validationAbility to independently manage projects and make sound statistical decisionsStrong communication skills and experience collaborating with cross-functional teams
Preferred: Exposure to statistical modeling, simulation methods, or PD/biomarker analyses.
Why It’s Special
Fully remote across CanadaHigh-impact early development workStrong balance of autonomy and collaborationOpportunity suited to someone senior yet still technically hands-onStable environment with long-term visibility
